4D Molecular Therapeutics
FDMT
FDMT
132 hedge funds and large institutions have $344M invested in 4D Molecular Therapeutics in 2025 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 30 increasing their positions, 48 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.55% less ownership
Funds ownership: 87.21% → 84.66% (-2.6%)
38% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 48
Holders
132
Holding in Top 10
–
Calls
$1.12M
Puts
$191K
Top Buyers
| 1 | +$6.92M | |
| 2 | +$2.75M | |
| 3 | +$1.74M | |
| 4 |
Renaissance Technologies
New York
|
+$1.71M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.56M |
Top Sellers
| 1 | -$3.25M | |
| 2 | -$2.91M | |
| 3 | -$2.39M | |
| 4 |
Two Sigma Investments
New York
|
-$2.24M |
| 5 |
Two Sigma Advisers
New York
|
-$1.68M |
